171 related articles for article (PubMed ID: 37592303)
21. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
[TBL] [Abstract][Full Text] [Related]
22. microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients.
Mari L; Hoefnagel SJM; Zito D; van de Meent M; van Endert P; Calpe S; Sancho Serra MDC; Heemskerk MHM; van Laarhoven HWM; Hulshof MCCM; Gisbertz SS; Medema JP; van Berge Henegouwen MI; Meijer SL; Bergman JJGHM; Milano F; Krishnadath KK
Gastroenterology; 2018 Sep; 155(3):784-798. PubMed ID: 29885883
[TBL] [Abstract][Full Text] [Related]
23. Cigarette smoke and decreased oxygen tension inhibit pulmonary claudin-6 expression.
Jimenez FR; Lewis JB; Belgique ST; Milner DC; Lewis AL; Dunaway TM; Egbert KM; Winden DR; Arroyo JA; Reynolds PR
Exp Lung Res; 2016; 42(8-10):440-452. PubMed ID: 27982694
[TBL] [Abstract][Full Text] [Related]
24. Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategies.
Moentenich V; Gebauer F; Comut E; Tuchscherer A; Bruns C; Schroeder W; Buettner R; Alakus H; Loeser H; Zander T; Quaas A
Oncol Lett; 2020 Jun; 19(6):3665-3670. PubMed ID: 32391091
[TBL] [Abstract][Full Text] [Related]
25. Claudin 6: Therapeutic prospects for tumours, and mechanisms of expression and regulation (Review).
Du H; Yang X; Fan J; Du X
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296304
[TBL] [Abstract][Full Text] [Related]
26. CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.
Yang M; Li Y; Shen X; Ruan Y; Lu Y; Jin X; Song P; Guo Y; Zhang X; Qu H; Shao Y; Quan C
J Exp Clin Cancer Res; 2017 Nov; 36(1):157. PubMed ID: 29116019
[TBL] [Abstract][Full Text] [Related]
27. Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma.
Lin L; Qin Y; Jin T; Liu S; Zhang S; Shen X; Lin Z
Exp Mol Pathol; 2014 Apr; 96(2):200-5. PubMed ID: 24384455
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.
Song P; Li Y; Dong Y; Liang Y; Qu H; Qi D; Lu Y; Jin X; Guo Y; Jia Y; Wang X; Xu W; Quan C
J Exp Clin Cancer Res; 2019 Aug; 38(1):354. PubMed ID: 31412908
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological Significance, Related Molecular Changes and Tumor Immune Response Analysis of the Abnormal SWI/SNF Complex Subunit PBRM1 in Gastric Adenocarcinoma.
Zhou Z; Huang D; Yang S; Liang J; Wang X; Rao Q
Pathol Oncol Res; 2022; 28():1610479. PubMed ID: 35928964
[No Abstract] [Full Text] [Related]
30. Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell-engaging bispecific antibody targeting human claudin 6.
Stadler CR; Ellinghaus U; Fischer L; Bähr-Mahmud H; Rao M; Lindemann C; Chaturvedi A; Scharf C; Biermann I; Hebich B; Malz A; Beresin G; Falck G; Häcker A; Houben A; Erdeljan M; Wolf K; Kullmann M; Chang P; Türeci Ö; Şahin U
Sci Transl Med; 2024 May; 16(748):eadl2720. PubMed ID: 38776391
[TBL] [Abstract][Full Text] [Related]
31. Evidence to Date on the Therapeutic Potential of Zolbetuximab in Advanced Gastroesophageal Adenocarcinoma.
Rogers JE; Ajani J
Curr Oncol; 2024 Feb; 31(2):769-777. PubMed ID: 38392051
[TBL] [Abstract][Full Text] [Related]
32. CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231.
Yang M; Li Y; Ruan Y; Lu Y; Lin D; Xie Y; Dong B; Dang Q; Quan C
Mol Cell Biochem; 2018 Jun; 443(1-2):169-180. PubMed ID: 29159771
[TBL] [Abstract][Full Text] [Related]
33. CLDN6: From Traditional Barrier Function to Emerging Roles in Cancers.
Qu H; Jin Q; Quan C
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948213
[TBL] [Abstract][Full Text] [Related]
34. CLDN6-induced apoptosis via regulating ASK1-p38/JNK signaling in breast cancer MCF-7 cells.
Guo Y; Lin D; Zhang M; Zhang X; Li Y; Yang R; Lu Y; Jin X; Yang M; Wang M; Zhao S; Quan C
Int J Oncol; 2016 Jun; 48(6):2435-44. PubMed ID: 27035750
[TBL] [Abstract][Full Text] [Related]
35. Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer.
Matsuzaki J; Lele S; Odunsi K; Tsuji T
Oncoimmunology; 2022; 11(1):2020983. PubMed ID: 35003898
[TBL] [Abstract][Full Text] [Related]
36. The Expression of the Claudin Family of Proteins in Colorectal Cancer.
Cox KE; Liu S; Hoffman RM; Batra SK; Dhawan P; Bouvet M
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540693
[TBL] [Abstract][Full Text] [Related]
37. Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options.
Skowron MA; Kotthoff M; Bremmer F; Ruhnke K; Parmaksiz F; Richter A; Küffer S; Reuter-Jessen K; Pauls S; Stefanski A; Ströbel P; Stühler K; Nettersheim D
Mol Med; 2023 Mar; 29(1):40. PubMed ID: 36991316
[TBL] [Abstract][Full Text] [Related]
38. Expression and prognostic value of cell-cycle-associated genes in gastric adenocarcinoma.
Wang D; Zhu H; Guo M; Fan X; Hu S; Yan K; Sun J; Wang J; Li M; Xiao H; Liu Z
BMC Gastroenterol; 2018 Jun; 18(1):81. PubMed ID: 29884122
[TBL] [Abstract][Full Text] [Related]
39. Hypermethylation of multiple Wnt antagonist genes in gastric neoplasia: Is H pylori infection blasting fuse?
Wang Z; Ye Y; Liu D; Yang X; Wang F
Medicine (Baltimore); 2018 Dec; 97(52):e13734. PubMed ID: 30593147
[TBL] [Abstract][Full Text] [Related]
40. Mir-421 and mir-550a-1 are potential prognostic markers in esophageal adenocarcinoma.
Ji Y; Wang L; Chang G; Yan J; Dai L; Ji Z; Liu J; He M; Xu H; Zhang L
Biol Direct; 2023 Feb; 18(1):5. PubMed ID: 36829221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
